Patents by Inventor Soren Moller Nielsen

Soren Moller Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Azaisoquinolinone derivatives as NK3 antagonists
    Publication number: 20130190499
    Abstract: The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Application
    Filed: March 11, 2011
    Publication date: July 25, 2013
    Applicant: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Klaus Bæk Simonsen, Søren Møller Nielsen, Karsten Juhl
  • Isoquinolinone derivatives as NK3 antagonists
    Patent number: 8420667
    Abstract: Isoquinolone derivatives of the general formula Ik? are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: April 16, 2013
    Assignee: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • Isoquinolinone derivatives as NK3 antagonists
    Patent number: 8415373
    Abstract: Isoquinolone derivatives of the general formula (I) are NK3 antagonists.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: April 9, 2013
    Assignee: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • Isoquinolinone derivatives as NK3 antagonists
    Patent number: 8415356
    Abstract: Isoquinolone derivatives of the general formula I are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Grant
    Filed: June 19, 2009
    Date of Patent: April 9, 2013
    Assignee: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Søren Møller Nielsen, Klaus Bæk Simonsen
  • Isoquinolinone derivatives as NK3 antagonists
    Patent number: 8242134
    Abstract: The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Grant
    Filed: September 11, 2009
    Date of Patent: August 14, 2012
    Assignee: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • Pyridone derivatives as NK3 antagonists
    Patent number: 8207347
    Abstract: The present invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: June 26, 2012
    Assignee: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Søren Møller Nielsen, Karsten Juhl, Lars Kyhn Rasmussen
  • Isoquinolinone derivatives as NK3 antagonists
    Patent number: 8173639
    Abstract: Isoquinolone derivatives of the general formula are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: May 8, 2012
    Assignee: H. Lundbeck A/S
    Inventors: Klaus Baek Simonsen, Jan Kehler, Karsten Juhl, Nikolay Khanzhin, Soren Moller Nielsen
  • ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
    Publication number: 20110288120
    Abstract: Isoquinolone derivatives of the general formula (I) are NK3 antagonists.
    Type: Application
    Filed: October 16, 2009
    Publication date: November 24, 2011
    Applicant: H. Lundbeck A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • AZAISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
    Publication number: 20110224247
    Abstract: The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Application
    Filed: March 11, 2011
    Publication date: September 15, 2011
    Applicant: H. LUNDBECK A/S
    Inventors: Nikolay Khanzhin, Klaus Bæk Simonsen, Søren Møller Nielsen, Karsten Juhl
  • Pyridone derivatives as NK3 antagonists
    Publication number: 20110144164
    Abstract: The present invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Application
    Filed: December 14, 2010
    Publication date: June 16, 2011
    Applicant: H. LUNDBECK A/S
    Inventors: Nikolay Khanzhin, Søren Møller Nielsen, Karsten Juhl, Lars Kyhn Rasmussen
  • ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
    Publication number: 20110130420
    Abstract: Isoquinolone derivatives of the general formula Ik? are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Application
    Filed: April 22, 2009
    Publication date: June 2, 2011
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
    Publication number: 20110130407
    Abstract: Isoquinolone derivatives of the general formula I are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Application
    Filed: June 19, 2009
    Publication date: June 2, 2011
    Applicant: H. LUNDBECK A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Søren Møller Nielsen, Klaus Baek Simonsen
  • Cyclopropyl derivatives as NK3 receptor antagonists
    Patent number: 7834008
    Abstract: The present invention relates to cyclopropyl derivatives of formula (I) and salt thereof. These compounds are NK3 receptor antagonists and may therefore be useful for treatment of diseases where the NK3 receptor is implicated, e.g. psychotic disorders.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: November 16, 2010
    Assignee: H. Lundbeck A/S
    Inventors: Jan Kehler, Tore Hansen, Anders Poulsen, Berith Bjørnholm, Thomas Ruhland, Morten Bang Nørgaard, Søren Møller Nielsen
  • ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
    Publication number: 20100076016
    Abstract: The invention relates to compounds useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
    Type: Application
    Filed: September 11, 2009
    Publication date: March 25, 2010
    Applicant: H. LUNDBECK A/S
    Inventors: Nikolay Khanzhin, Karsten Juhl, Soren Moller Nielsen, Klaus Baek Simonsen
  • ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS
    Publication number: 20090143402
    Abstract: Isoquinolone derivatives of the general formula are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.
    Type: Application
    Filed: April 11, 2008
    Publication date: June 4, 2009
    Applicant: H. LUNDBECK A/S
    Inventors: Klaus Baek Simonsen, Jan Kehler, Karsten Juhl, Nikolay Khanzhin, Soren Moller Nielsen